Skip to content

Daily Irrigation With Silicone Hydrogel Contact Lens Continuous Wear

Effects of Daily Irrigation on Corneal Epithelial Permeability and Adverse Events With Silicone Hydrogel Contact Lens Continuous Wear

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03139812
Acronym
EW23
Enrollment
161
Registered
2017-05-04
Start date
2012-01-15
Completion date
2012-10-15
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Epithelial Permeability

Keywords

continuous contact lens wear, silicone hydrogel contact lenses, irrigation, corneal epithelial permeability, contact lens-related adverse events

Brief summary

This study sought to determine whether daily irrigation with sterile saline solution during silicone hydrogel (SiH) contact lens continuous wear (CW) could improve ocular surface integrity and reduce the risk of adverse events.

Detailed description

The purpose of this study was to determine whether daily irrigation with sterile saline solution during silicone hydrogel (SiH) contact lens 30-day continuous wear (CW) can mitigate increases in corneal epithelial permeability (Pdc) and reduce the risk of mechanical, contact lens-induced, inflammatory, and overall adverse events. 161 non-contact lens wearers were fit with SiH contact lenses and randomized to either a treatment (n = 81) or control (n = 80) group for 30-day CW. Subjects in the treatment group irrigated every morning and whenever dryness symptoms occurred; subjects in the control group did not.

Interventions

DRUGDaily irrigation

Daily morning irrigation of the eye with sterile, borate-buffered, saline solution (Unisol 4) and gentle nudging of the lens to promote solution flow beneath the lens

DEVICE30-day SiH CW

30-day continuous wear of silicone hydrogel contact lenses

Sponsors

University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Masking description

Research optometrists conducting eye examinations and technicians conducting fluorometry measurements did not know whether a given subject was in the treatment (irrigating) or control (non-irrigating) group.

Intervention model description

161 non-contact lens wearers were fit with silicone hydrogel (SiH) contact lenses and randomized to either a treatment (n = 81) or control (n = 80) group for 30-day continuous wear (CW). Subjects in the treatment group irrigated every morning and whenever dryness symptoms occurred; subjects in the control group did not.

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* spectacle prescriptions between -1.00 diopter sphere (DS) and -10.00 DS; * less than 0.75 diopters (D) of astigmatism; * free of any ocular disease or systemic disease with ocular manifestation;

Exclusion criteria

* history of contact lens wear within the past year; * history of ocular surgery or serious injury; * presence of corneal scarring; * frequent swimming, smoking, or use of medications w/ ocular side effects;

Design outcomes

Primary

MeasureTime frameDescription
Corneal epithelial permeability (Pdc) Post-30-Day CWPost-30-Day CW of SiH contact lensesRate of fluorescein clearance through the corneal epithelium, measured by scanning fluorometry, in nm/sec after 30 nights of contact lens CW
Corneal epithelial permeability (Pdc) at BaselineBaselineRate of fluorescein clearance through the corneal epithelium, measured by scanning fluorometry, in nm/sec at baseline with no contact lenses
Corneal epithelial permeability (Pdc) Post-1-Day CWPost-1-Day CW of SiH contact lensesRate of fluorescein clearance through the corneal epithelium, measured by scanning fluorometry, in nm/sec after 1 night of contact lens CW
Risk of adverse eventsPost-30-day CW of SiH contact lensesOdds ratios (OR) for adverse events: contact lens-induced, mechanically-induced, inflammatory, and overall

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026